Renal Function at Two Years in Liver Transplant Patients Receiving Everolimus: Results of a Randomized, Multicenter Study-Reference-Cited by-同舟云学术

Renal Function at Two Years in Liver Transplant Patients Receiving Everolimus: Results of a Randomized, Multicenter Study

Published:2013-05-28 Issue:7 Volume:13 Page:1734-1745
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:

Author:

Saliba F.¹,De Simone P.²,Nevens F.³,De Carlis L.⁴,Metselaar H. J.⁵,Beckebaum S.,Jonas S.⁶,Sudan D.⁷,Fischer L.⁸,Duvoux C.⁹,Chavin K. D.¹⁰,Koneru B.¹¹,Huang M. A.¹²,Chapman W. C.¹³,Foltys D.¹⁴,Dong G.¹⁵,Lopez P. M.¹⁶,Fung J.¹⁷,Junge G.¹⁶,

Affiliation:

1. Hepatobiliary Center, AP-HP Hôpital Paul Brousse; Université Paris-Sud; Villejuif; France

2. General Surgery and Liver Transplantation; Azienda Ospedaliero-Universitaria Pisana; Pisa; Italy

3. Department of Hepatology; University Hospital KU Leuven; Leuven; Belgium

4. Department of General Surgery and Transplantation; Azienda Ospedaliera Niguarda Cà Granda; Milan; Italy

5. Department of Gastroenterology and Hepatology; Erasmus MC, University Hospital Rotterdam; Rotterdam; the Netherlands

6. Department of Visceral, Transplantation, Thoracic and Vascular Surgery; University Medical Center Leipzig; Leipzig; Germany

7. Division of Transplant Surgery, Department of General Surgery; Duke University Medical Center; Durham; NC

8. Department of Hepatobiliary Surgery and Transplantation; University Medical Center Eppendorf; Hamburg; Germany

9. Liver Transplant Unit; AP-HP Hôpital Henri Mondor; Créteil; France

10. Division of Transplant Surgery; Medical University of South Carolina; Charleston; SC

11. Department of Surgery; University of Medicine and Dentistry-New Jersey Medical School; Newark; NJ

12. Division of Gastroenterology, Department of Internal Medicine; Henry Ford Hospital; Detroit; MI

13. Department of Surgery; Washington University School of Medicine; St Louis; MO

14. Department of Transplant Surgery; University Medical Center, Johannes Gutenberg University; Mainz; Germany

15. Novartis Pharmaceuticals; East Hanover; NJ

16. Novartis Pharma AG; Basel; Switzerland

17. Transplantation Center, Cleveland Clinic; Cleveland; OH

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference23 articles.

1. Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients;Tedesco Silva;Am J Transplant,2010

2. Calcineurin inhibitor-sparing regimens in solid organ transplantation: Focus on improving renal function and nephrotoxicity;Flechner;Clin Transplant,2008

3. Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: A prospective, randomized, multicenter trial;De Simone;Liver Transpl,2009

4. Conversion to everolimus in maintenance liver transplant patients: A multicenter, retrospective analysis;Saliba;Liver Transpl,2011

5. Early withdrawal of calcineurin inhibitors and everolimus monotherapy in de novo liver transplant recipients preserves renal function;Masetti;Am J Transplant,2010

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post Liver Transplant Renal Dysfunction—Evaluation, Management and Immunosuppressive Practice;Journal of Clinical and Experimental Hepatology;2024-03

2. Risk factors for incisional hernia after liver transplantation in the era of mammalian target of rapamycin inhibitors use: a retrospective study of living donor liver transplantation dominant center in Korea;Annals of Surgical Treatment and Research;2024

3. Long Term Complications of Immunosuppression Post Liver Transplant;Journal of Clinical and Experimental Hepatology;2023-11

4. De novo mTOR inhibitor immunosuppression versus calcineurin inhibitor immunosuppression for liver transplant recipients;Cochrane Database of Systematic Reviews;2023-08-04

5. Chronic Kidney Disease After Liver Transplantation;Advances in Kidney Disease and Health;2023-07